These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34422350)

  • 1. Predictors of residual pulmonary vascular obstruction after anticoagulation monotherapy in patients with intermediate-risk pulmonary embolism.
    Chang Y; Moon JY; Park JH; Choi S; Lee HP; Sim JK; Lee YS
    J Thorac Dis; 2021 Jul; 13(7):4217-4227. PubMed ID: 34422350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of Residual Pulmonary Vascular Obstruction after Acute Pulmonary Embolism Based on Patient Variables and Treatment Modality.
    Ho TA; Pescatore J; Lio KU; Rali P; Criner G; Gayen S
    J Clin Med; 2024 Jul; 13(14):. PubMed ID: 39064289
    [No Abstract]   [Full Text] [Related]  

  • 3. Detection of Residual Pulmonary Vascular Obstruction by Ventilation-Perfusion Lung Scan Late After a First Pulmonary Embolism.
    Chopard R; Genet B; Ecarnot F; Chatot M; Napporn G; Hyvert A; Didier-Petit K; Schiele F; Meneveau N
    Am J Cardiol; 2017 Jun; 119(11):1883-1889. PubMed ID: 28400030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of residual pulmonary vascular obstruction after pulmonary embolism: Results from a prospective cohort study.
    Picart G; Robin P; Tromeur C; Orione C; Raj L; Ferrière N; Le Mao R; Le Roux PY; Le Floch PY; Lemarié CA; Nonent M; Leroyer C; Guegan M; Lacut K; Salaün PY; Couturaud F
    Thromb Res; 2020 Oct; 194():1-7. PubMed ID: 32554255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishing a risk prediction model for residual pulmonary vascular obstruction after regular anticoagulant therapy for non-high-risk pulmonary embolism.
    Zhu D; Feng J; Guo J; Duan J; Yang Y; Leng J
    J Thorac Dis; 2024 Jul; 16(7):4447-4459. PubMed ID: 39144299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced fibrin clot permeability on admission and elevated E-selectin at 3 months as novel risk factors of residual pulmonary vascular obstruction in patients with acute pulmonary embolism.
    Stępień K; Ząbczyk M; Kopytek M; Natorska J; Zalewski J; Undas A
    J Thromb Thrombolysis; 2024 Feb; 57(2):248-259. PubMed ID: 37932588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What's next after the clot? Residual pulmonary vascular obstruction after pulmonary embolism: From imaging finding to clinical consequences.
    Bonnefoy PB; Margelidon-Cozzolino V; Catella-Chatron J; Ayoub E; Guichard JB; Murgier M; Bertoletti L
    Thromb Res; 2019 Dec; 184():67-76. PubMed ID: 31710860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors and treatment interventions associated with incomplete thrombus resolution and pulmonary hypertension after pulmonary embolism.
    Fang A; Mayorga-Carlin M; Han P; Cassady S; John T; LaRocco A; Etezadi V; Jones K; Nagarsheth K; Toursavadkohi S; Jeudy J; Anderson D; Griffith B; Sorkin JD; Sarkar R; Lal BK; Cires-Drouet RS
    J Vasc Surg Venous Lymphat Disord; 2024 Jan; 12(1):101665. PubMed ID: 37595746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term prognostic value of residual pulmonary vascular obstruction at discharge in patients with intermediate- to high-risk pulmonary embolism.
    Meneveau N; Ider O; Seronde MF; Chopard R; Davani S; Bernard Y; Schiele F
    Eur Heart J; 2013 Mar; 34(9):693-701. PubMed ID: 23103660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Residual pulmonary vascular obstruction and recurrence after acute pulmonary embolism. A single center cohort study.
    Planquette B; Ferré A; Peron J; Vial-Dupuy A; Pastre J; Mourin G; Emmerich J; Collignon MA; Meyer G; Sanchez O
    Thromb Res; 2016 Dec; 148():70-75. PubMed ID: 27815969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Residual Pulmonary Vascular Obstruction Following Mechanical Thrombectomy for Submassive Pulmonary Embolism: A Single-Center Analysis.
    Stegman B; Kumar A; Dahle T; Schmidt W; Dutcher J; Glenz T; Appelbaum D
    J Soc Cardiovasc Angiogr Interv; 2024 Feb; 3(2):101260. PubMed ID: 39132216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Residual pulmonary vascular obstruction and recurrence after acute pulmonary embolism: a systematic review and meta-analysis of individual participant data.
    Robin P; Le Pennec R; Eddy M; Sikora L; Le Roux PY; Carrier M; Couturaud F; Tromeur C; Planquette B; Sanchez O; Pesavento R; Filippi L; Rodger MA; Kovacs MJ; Mallick R; Salaun PY; Le Gal G
    J Thromb Haemost; 2023 Jun; 21(6):1519-1528.e2. PubMed ID: 36740040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrinogen and the prediction of residual obstruction manifested after pulmonary embolism treatment.
    Planquette B; Sanchez O; Marsh JJ; Chiles PG; Emmerich J; Le Gal G; Meyer G; Wolfson T; Gamst AC; Moore RE; Gugiu GB; Morris TA
    Eur Respir J; 2018 Nov; 52(5):. PubMed ID: 30337447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thromboembolic resolution assessed by CT pulmonary angiography after treatment for acute pulmonary embolism.
    den Exter PL; van Es J; Kroft LJ; Erkens PM; Douma RA; Mos IC; Jonkers G; Hovens MM; Durian MF; ten Cate H; Beenen LF; Kamphuisen PW; Huisman MV;
    Thromb Haemost; 2015 Jul; 114(1):26-34. PubMed ID: 26017397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Right ventricular dysfunction and pulmonary obstruction index at helical CT: prediction of clinical outcome during 3-month follow-up in patients with acute pulmonary embolism.
    van der Meer RW; Pattynama PM; van Strijen MJ; van den Berg-Huijsmans AA; Hartmann IJ; Putter H; de Roos A; Huisman MV
    Radiology; 2005 Jun; 235(3):798-803. PubMed ID: 15845793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors for Residual Pulmonary Vascular Obstruction after Unprovoked Pulmonary Embolism: Implications for Clinical Practice-The PADIS-PE Trial.
    Raj L; Robin P; Le Mao R; Presles E; Tromeur C; Sanchez O; Pernod G; Bertoletti L; Jego P; Leven F; Lemarié CA; Martin A; Planquette B; Le Roux PY; Salaun PY; Nonent M; Girard P; Lacut K; Melac S; Mismetti P; Laporte S; Meyer G; Leroyer C; Couturaud F;
    Thromb Haemost; 2019 Sep; 119(9):1489-1497. PubMed ID: 31230343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managing pulmonary embolism from presentation to extended treatment.
    Cohen AT; Dobromirski M; Gurwith MM
    Thromb Res; 2014 Feb; 133(2):139-48. PubMed ID: 24182642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and risk factors of chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism.
    Yang S; Yang Y; Zhai Z; Kuang T; Gong J; Zhang S; Zhu J; Liang L; Shen YH; Wang C
    J Thorac Dis; 2015 Nov; 7(11):1927-38. PubMed ID: 26716031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial thrombolysis treatment compared with anticoagulation for acute intermediate-risk pulmonary embolism: a meta-analysis.
    Xu Q; Huang K; Zhai Z; Yang Y; Wang J; Wang C
    J Thorac Dis; 2015 May; 7(5):810-21. PubMed ID: 26101636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and management of life-threatening pulmonary embolism.
    Marshall PS; Mathews KS; Siegel MD
    J Intensive Care Med; 2011; 26(5):275-94. PubMed ID: 21606060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.